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Cotranslational Biogenesis of NF-kB p50
by the 26S Proteasome
present in IkB-a. In this regard, p105 binds to and se-
questers other Rel-related proteins in the cytoplasm,
thereby functioning as an IkB (Rice et al., 1992). Thus,
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despite sharing an identical N-terminal Rel homology²Department of Medicine
domain, p50 and p105 subserve quite different biologi-³Department of Microbiology and Immunology
cal functions in the cell.University of California
Like IkB-a, p105 is basally phosphorylated and under-San Francisco, California 94141
goes additional phosphorylation upon cellular stimula-§Department of Physiology
tion (Mercurio et al., 1993; Naumann and Scheidereit,University of Texas Southwestern Medical Center
1994; MacKichan et al., 1996). However, unlike the sig-Dallas, Texas 75235
nal-coupled phosphorylation of serines 32 and 36 in
IkB-a (Lin et al., 1995; Traenckner et al., 1995), which
leads to the degradation of this inhibitor within the 26SSummary
proteasome (Henkel et al., 1993; Chen et al., 1995;
Scherer et al., 1995), phosphorylation of the C terminusThe NFKB1 gene encodes two functionally distinct
of p105 produces no clear functional consequences.
proteins termed p50 and p105. p50 corresponds to
Mitogenic stimuli have been reported to moderately in-
the N terminus of p105 and with p65 (RelA) forms the
crease p50 expression (Mercurio et al., 1993; Donald et
prototypical NF-kB transcription factor complex. In al., 1995); however, large amounts of p50 are present
contrast, p105 functions as a Rel-specific inhibitor in unstimulated cells, suggesting that mitogenic stimula-
(IkB) and has been proposed to be the precursor of tion is not obligately required for p50 generation. Addi-
p50. Our studies now demonstrate that p50 is gener- tionally, the candidate oncoprotein BCL-3 induces p50
ated by a unique cotranslational processing event in- homodimers from cytosolic p105/p50 complexes with-
volving the 26S proteasome, whereas cotranslational out enhancing the processing of p105 (Watanabe et
folding of sequences near the C terminus of p50 abro- al., 1997). Finally, a glycine-rich region (GRR) between
gates proteasome processing and leads to p105 pro- amino acids 375-401 in p105 is required for p50 genera-
duction. These results indicate that p105 is not the tion both in COS cells (Lin and Ghosh, 1996) and rabbit
precursor of p50 and reveal a novel mechanism of reticulocyte lysates (Lin and Greene, unpublished data).
gene regulation that ensures the balanced production Of note, sequences downstream of the GRR can be
and independent function of thep50 and p105 proteins. replaced with heterologous elements (Betts and Nabel,
1996; Lin and Ghosh, 1996), suggesting that this region
Introduction does not contain sequence-specific elements required
for p50 production.
The eukaryotic transcription factor, NF-kB, is a hetero- The generation of p50 appears to involve the 26S
dimeric complex composed of two polypeptide subunits proteasome as first indicated by the requirement for
termed p50 and p65 (RelA). Normally, NF-kB is seques- ATP (Fan and Maniatis, 1991) and later by the use of
tered in the cytosol by a family of ankyrin motif-rich proteasome inhibitors (Palombella et al., 1994). Genera-
inhibitors termed the IkBs (Baeuerle and Baltimore, tion of p50 is also defective in a yeast strain mutated in
1988). However, extracellular stimuli, including tumor the PRE1 proteasome subunit gene (Palombella et al.,
necrosis factor a (TNFa), lipopolysaccharide (LPS), and 1994). Thus far, p105 and perhaps the closely related
phorbol esters, lead to the nuclear expression of NF-kB NFKB2 gene product, p100, are the only examples of
(for review, Baeuerle and Henkel, 1994; Siebenlist et al., proteasome substrates that are processed rather than
1994; Thanos and Maniatis, 1995; Verma et al., 1995; completely degraded. How the N-terminal portion of
Baeuerle and Baltimore, 1996; Baldwin, 1996), which in p105 is spared from complete degradation by the pro-
turn regulates an array of genes involved in immune, teasome remains an enigma.
We now describe a series of studies demonstratinginflammatory, and antiapoptotic responses (Beg et al.,
that full-length p105 is not the primary precursor of p50.1995; Sha et al., 1995; Beg and Baltimore, 1996; Van
Rather, p50 is generated cotranslationally by a protea-Antwerp et al., 1996; Wang et al., 1996).
some-mediated process that ensures the production ofThe p105 protein is encoded by the NFKB1 gene
both p50 and p105 and preserves their independent(Ghosh et al., 1990; Kieran et al., 1990). The N-terminal
functions. Our results further suggest that cotransla-portion of p105 corresponds to the p50 subunit of the
tional folding of the N-terminal portion of p105 protectsprototypical NF-kB complex. These p50 molecules ei-
this region that forms p50 from degradation by the pro-ther assemble with other Rel family members, including
teasome, whereas folding of sequences downstream ofp65 and c-Rel, or alternatively self-assemble as homodi-
the GRR precludes processing altogether, leading tomers (Henkel et al., 1992; Rice et al., 1992; Naumann et
p105 production. These findings highlight a previouslyal., 1993). The C-terminal portion of p105 is remarkable
unrecognized mechanism of gene regulation in mamma-for the presence of ankyrin repeats resembling those
lian cells and provide a natural example for the proposed
sequential and cotranslational folding of eukaryotic pro-
teins (Netzer and Hartl, 1997).‖ To whom correspondence should be addressed.
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Figure 1. Pulse-Chase Studies of p50 Gener-
ation
(A) Pulse-chase analysis of p50 generation in
vivo. CHO-CD14 cells transfected with p105
expression vector DNA were pulse-radiola-
beled with [35S]methionine/cysteine and chased
for the time periods indicated. The 1 hr pulse
radiolabeling point was regarded as time 0
for the chase (lane 3).
(B) Pulse-chase analysis of p50 generation
in vitro. mRNA encoding the N-terminal 497
amino acids of p105 was used to program
translation in rabbit reticulocyte lysates.
(C) Densitometry analysis of the time course
of p50 generation. Production of p50 was as-
sessed by densitometry throughout the time
course of the in vitro pulse-chase study.
Results in p50 and thus appears to result from the degradation
of p105, as previously suggested (Harhaj et al., 1996),
rather than processing to p50. These findings suggestedNF-kB p105 and p50 Do Not Exhibit a Classical
Precursor±Product Relationship in Pulse-Chase that the generation of p50 may be closely linked with
translation.Radiolabeling Studies
Earlier studies suggested a precursor±product relation-
ship between p105 and p50 either in the absence (Fan A Nascent but Not Folded 497±Amino Acid Fragment
of p105 Is Sufficient to Generate p50and Maniatis, 1991) or presence of mitogen stimulation
(Mercurio et al., 1993; Donald et al., 1995; Rousset et Although the C-terminal portion of p105 can be substi-
tuted with foreign sequences without affecting p50 gen-al., 1996). However, the generation of p50 was slow and
substantial quantities of p50 were evident before the eration (Betts and Nabel, 1996; Lin and Ghosh, 1996),
we tested whether the same 497±amino acid fragmentinitiation of chase in these studies. To assess the rela-
tionship between p105 and p50 further, we performed used in in vitro translation was processed in vivo. Sur-
prisingly, even though the full-length 497±amino acidpulse-chase radiolabeling experiments in CHO-CD14
cells transfected with a mouse p105 cDNA expression protein was stably expressed in CHO-CD14 cells and
p105 was normally processed to p50 (Figure 2B, lanevector, harvesting multiple samples during both pulse
and chase periods (Figure 1A). Increasing amounts of 1), virtually no p50 was generated from p-497 (Figure
2B, lane 2). This lack of processing of the497±amino acidboth p105 and p50 were readily detected at each of
pulse radiolabeling time points (lanes 1±3). Even though fragment in vivo thus differed sharply from the results
obtained with this same fragment in vitro (Figure 1B).p105 levels declined during the 6 hr chase period, no
corresponding increase in p50 radiolabeling was de- Both vectors expressed the same 497±amino acid poly-
peptide; however, p-497 contained a stop codon follow-tected (lanes 4±7). Similarly, in pulse-chase studies
performed in vitro using rabbit reticulocyte lysates pro- ing residue 497, while the mRNA used in in vitro expres-
sion was truncated by restriction of the DNA templategrammed with mRNA encoding a 497±amino acid frag-
ment of p105, we observed essentially simultaneous with XhoI prior to transcription.
To determine whether theobserved differences in p50radiolabeling of p50 and the larger polypeptide during
the initial pulse radiolabeling phase (Figure 1B, lanes generation in vivo and in vitro reflected the presence or
absence of a stop codon, the p-497/XhoI fragment was3±5). Additionally, the radiolabel present in the 497±
amino acid protein did not chase to p50 during the sub- reengineered with a stop codon (p-497/Stop) and tested
for p50 generation in vitro. As shown in Figure 2C (lanesequent 6 hr incubation period. Densitometric analyses
of the production of p50 in these in vitro (Figure 1C) and 2), the 497±amino acid protein translated from an mRNA
containing a stop codon yielded little p50. In contrastin vivo (data not shown) studies indicate that p50 is
rapidly generated during the pulse period but only slowly and as shown previously, significant amounts of p50
were generated from mRNA derived from the p-497/accumulates during the subsequent chase. The disap-
pearance of p105 during the chase phase of the in vivo XhoI vector (Figure 2C, lane 1).
These findings are revealing because in the absencestudies (Figure 1A) was not accompanied by an increase
Cotranslational Biogenesis of NF-kB p50
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Figure 2. Differential Processing of a 497-
Amino Acid N-terminal Fragment of p105
from mRNAs Containing orLacking a Transla-
tion Stop Codon
(A) Diagram of the 497±amino acid p105
N-terminal fragment employed in the study.
The fragment contains the glycine-rich region
(GRR) and spans beyond the estimated C ter-
minus of p50 located at residue 433.
(B) Expression andprocessing of p105 versus
the 497±amino acid N-terminal fragment of
p105 in vivo. T7 gp10 epitope±tagged p105
and p-497 were transfected into CHO-CD14
cells and radiolabeled as described in Figure
1. Lysates were prepared and immunoprecip-
itated. Lane1, wild-type p105; lane 2, the 497±
amino acid fragment of p105; lane 3, control
cells transfected with empty vector.
(C) In vitro translation of the p105-derived
497±amino acid fragment from mRNAs either
lacking or containing a translation stop co-
don. The two mRNAs derived from p-497/
XhoI (lane 1, lacking a stop codon) or p-497/
Stop (lane 2, containing a stop codon) were
translated in rabbit reticulocyte lysates, and
the protein products from both translations
were immunoprecipitated with anti-p105 spe-
cific antisera. Lane 3, immunoprecipitation of control lysates not programmed with mRNA.
(D) The Hsc70 chaperone binds to the nascent but not folded form of the 497±amino acid fragment of p105. mRNAs lacking (lane 1) or
containing (lane 2) a stop codon following the N-terminal 497 amino acids of p105 were translated in rabbit reticulocyte lysates. Translation
was synchronized by the addition of ATCA (75 mM, final concentration) 3 min after initiation. The arrow indicates coimmunoprecipitation of
the 497±amino acid fragment of p105 translated from an mRNA lacking a stop codon by antibodies specific for Hsc 70.
of a stop codon, the ribosome stalls at the end of the allow the generation of p50. To determine how much
additional translation is required for p50 production, wemRNA and the nascent polypeptide remains bound to
the ribosome as a peptidyl tRNA (Krieg et al., 1989). In moved the stop codon progressively downstream of
residue 497 and tested these p105-derived fragmentsaddition, this peptide fails to undergo posttranslational
folding (Frydman et al., 1994).Elimination of stopcodons in vivo (Figure 3B) and invitro (Figure 3C) for p50 produc-
tion. An overview of p105 with various landmarks ishas been used to study the folding of nascent polypep-
tides and their interactions with molecular chaperones provided in Figure 3A. As expected, p105 mRNAs termi-
nating after residue 481 or 497 did not support p50(Frydman et al., 1994; Hansen et al., 1994; Frydman
and Hartl, 1996; Komar et al., 1997). To verify that the generation (Figure 3B, lanes 2 and 3). Similarly, reposi-
tioning of the stop codon following residue 504, 509, or497±amino acid fragment lacking the stop codon was
in a nascent state, aurintricarboxylic acid (ATCA) syn- 514 did not lead to significant p50 production in vivo
(Figure 3B, lanes 4±6). However, introduction of the stopchronized in vitro translations (Stewart et al., 1971; Fryd-
man et al., 1994) were performed and the protein prod- codon after residue 530 or further downstream resulted
in significant p50 accumulation (lanes 7±9). When a simi-ucts immunoprecipitated with an antibody specific for
the Hsc70 chaperone. Hsc70 exhibits high affinity for lar ªstop codon scanº was carried out in vitro, insertion
of the stop codon after residue 514 supported p50 gen-nascent or unfolded polypeptides but binds poorly to
folded proteins (Beckmann et al., 1990). As shown in eration (Figure 3C, lane 3). We suspect that the different
boundaries obtained in the in vivo and in vitro assaysFigure 2D, the anti-Hsc70 coimmunoprecipitated the
497±amino acid fragment derived from p-497/XhoI but (residue 530 vs. 514) may stem from the slower rate of
translation and protein folding that occurs in vitro. Ofdid not coimmunoprecipitate the 497±amino acid frag-
ment produced from p-497/Stop. The anti-Hsc70 anti- note, Fan and Maniatis (1991) similarly observed that a
human p105 deletion mutant terminating at residue 504body also did not coimmunoprecipitate the p50 protein
generated from the nascent 497±amino acid fragment failed to generate p50 in transfected COS cells. To-
gether, these results indicate that in the natural situation,(Figure 2D, lane 1), suggesting that this product is rapidly
folded. Together, these results indicate that premature continuing translation to a point approximately 100 amino
acids beyond the C terminus of p50 (residue 433; Linrelease and folding of a 497±amino acid fragment of
p105 abolishes the generation of p50. In contrast, the and Ghosh, 1996) is required for the generation of p50.
same polypeptide efficiently generates p50 if it remains
nascent. p50 Is Generated Prior to Completion
of Translation of Full-Length p105
To test further the possibility of cotranslational produc-Translation beyond Amino Acid 497 of p105
Permits the Generation of p50 tion of p50, ATCA synchronized in vitro translations were
performed for specific periods of time, followed by theSince wild-type p105 generates p50, we reasoned that
continuing translation beyond amino acid 497 should addition of puromycin to interrupt further translational
Cell
822
Figure 3. A Stop Codon Scan of p105
(A) Overview of the mouse p105 protein.
Known functional domains and relevant
amino acids are indicated.
(B) Stop codon scanning to evaluate p105
processing in vivo. Different C-terminal dele-
tions of p105 were prepared by inserting stop
codons betweenresidues 481and 564. These
constructs were expressed in CHO-CD14
cells and analyzed for processing to p50 by
immunoblotting. Lane 1 depicts results ob-
tained with vector DNA, while lane 10 shows
the results obtained with wild-type p105. The
name of each experimental plasmid indicates
the number of N-terminal residues of p105
present in the resultant protein.
(C) Stop codon scanning to evaluate p105
processing in vitro. p105 cDNAs containing
a nested set of progressive 39 deletions fol-
lowed by a stop codon were transcribed and
translated in rabbit reticulocyte lysates and
immunoprecipitated with anti-p105 (NLS) an-
tibody. The name of each plasmid indicates
the number of N-terminal residues present in
the p105-derived fragment.
elongation (Blobel and Sabatini, 1971). To separate p50 p105-derived fragment. Similar results were obtained
using a 781±amino acid fragment of p105 (data notgeneration and the completion of translation temporally,
a 646±amino acid version of p105 and a translation tem- shown).
perature of 258C were selected. Under these conditions,
translation proceeded at an average rate of 60 amino Cotranslational Biogenesis of p105 and p50
acids per min, similar to that observed in prior studies Is Influenced by Sequences Located
with luciferase (Frydman et al., 1994). In these synchro- Downstream of the GRR
nized translations, p50 production was observed at 9
In most cells, p105 and p50 are produced in nearly equiv-
min, indicating the synthesis of approximately 540
alent amounts (Naumann et al., 1993; Lin and Ghosh,
amino acids (Figure 4, lane 7). In contrast, translation
1996). Similarly, the nascent 497±amino acid fragment
of the larger 646±amino acid fragment required approxi-
is not completely processed to p50 but rather yields a
mately 11 min (Figure 4, lane 10). Thus, the generation
roughly balanced ratio of the two proteins (Figure 2C,
of p50 occurs well before complete synthesis of the
lane 1). This incomplete processing raises the possibility
that this process may be stochastic in nature. Since
folding of nascent polypeptides occurs cotranslationally
and the N-terminal portion of a protein may adopt a
native conformation before the completion of C-terminal
synthesis (Komar et al., 1997), it seemed possible that
such cotranslational folding of p105 might influence the
ratio of the products generated. A prior study has shown
that replacement of the entire C terminus of p105 with
T7 gp10 or IkB-a enhances p50 generation (Lin and
Ghosh, 1996). To test whether sequences immediately
surrounding the C terminus of p50 (approximately resi-
due 433) might influence the ratio of p50 and p105 pro-
duction, we fused the N-terminal region of either the T7
gp10 or the IkB-a genes to the GRR ending at residue
Figure 4. NF-kB p50 Is Generated Prior to the Synthesis of the Full- 401 to generate 497±amino acid fusion proteins (Figure
Length Protein
5A). Since these gene products contain different 96±
An mRNA encoding a 617±amino acid p105 N-terminal fragment amino acid sequences between the GRR and the C ter-
plus an N-terminal T7 gp10 and C-terminal His epitope tag (646 total
minus, their local propensity to fold cotranslationallyamino acids) was used to program translation in rabbit reticulocyte
might varyand bereflected by differences inp50 genera-lysates. The time points when p50 and the full-length protein were
first detected are indicated by vertical arrows (lane 7, 9 min for tion. Expression of the p50/Dgp10 chimeric protein in
p50; lane 10, 11 min for the full-length protein). An immunoreactive CHO-CD14 cells revealed markedly enhanced genera-
fragment slightly smaller than p50 was noted at 8 min (lane 5), tion of p50 compared to p-497, which generated very
which gradually diminished at later time points. This product could littlep50 (Figure 5B, compare lanes 2 and 4).Substitution
represent an aberrantly processed form of p50 resulting from the
of the same segment with 96 amino acids from IkB-ainterruption of translation. The control shown in lane 13 corresponds
moderately enhanced p50 generation (compare lanes 2to an unsynchronized translation performed at 258C for 25 min and
immunoprecipitated identically to the other samples. and 6). To exclude the possibility that these observed
Cotranslational Biogenesis of NF-kB p50
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Figure 5. Sequences Positioned Downstream of the p105 GRR Modulate the Ratio of p50 and p105 Production
(A) Diagram of the various chimeric proteins prepared and analyzed in these studies. The gp10 and IkB-a peptide fragments fused in-frame
distal to the GRR of p105, and their lengths are indicated respectively by the cross-hatching and stripes.
(B) Generation of p50 from the different chimera constructs. Each of the chimeras was expressed in CHO-CD14 cells, and the subsequent
lysates were analyzed by immunoblotting using the anti-p105 (NLS) antibody. The p50 Dgp10 full-length protein migrated slightly faster than
the 497 residue fragment of p105, presumably due to its different amino acid composition.
(C) Immunoblotting of the p50/gp10-derived lysates with anti-gp10 antibody. The control full-length gp10 protein (345 amino acids) expressed
in CHO-CD14 cells is shown in lane 3, while results obtained with the empty vector control are shown in lane 4.
(D) Immunoblotting of the p50/IkB-a-derived lysates with antibodies specific for the N terminus of IkB-a (C-15). Control recombinant IkB-a
protein expressed in E. coli is shown in lane 3 and the empty vector control in lane 4.
differences in p50 generation reflected different reactiv- to the biologically active form of this inhibitor (Dick et al.,
1996, 1997). The addition of clasto-lactacystin b-lactoneity of the chimeras with the anti-p50 antibody, the ex-
tracts from the p50/Dgp10 and p50/DIkB-a transfected at concentrations as low as 10 mM inhibited the genera-
tion of p50 while not altering the production of p105cells were immunoblotted with antibodies specific for
gp10 and IkB-a, respectively (Figures 5C and 5D). These (Figure 6, compare lanes 1±4 with lanes 5±8). When
added at the same concentration, clasto-lactacystinstudies confirmed enhanced generation of p50 with both
chimeric proteins (compare lane 2 of Figure 5B with b-lactone also inhibited LPS-induced degradation of
IkB-a in the CHO-CD14 cells (data not shown).Figures 5C and 5D). Thus, changing the amino acid in
the 96±amino acid segment that adjoins the GRR and To detect a potential direct interaction of p105 with
the proteasome, CHO-CD14 cells were transfected withencompasses the C terminus of p50 and additional
downstream sequences likely alters the folding of this p105, p-497, or p50 expression vectors containing a T7
gp10 immunoepitope followed by pulse radiolabelingregion and influences the stochastic process that deter-
mines the ratio of p50 and p105 produced. with [35S]methionine/cysteine for 1 hr and chasing for
30 min. Radiolabeling was performed both in the pres-
ence and absence of the MG115 proteasome inhibitor.The 26S Proteasome Mediates Cotranslational
Processing of p105 The lysates from these transfections were immunopre-
cipitated either with anti-gp10 or E446-1, an antibodyWe next examined the involvement of the 26S protea-
some in the cotranslational generation of p50. Produc- that reacts with the 20S proteasome. As shown in lane
8 of Figure 7, E446-1 effectively coimmunoprecipitatedtion of p50 was studied in the presence of a Streptomy-
ces noursei±derived metabolite lactacystin, which is a p105 but very little p50. However, newly synthesized
p50 encoded by a p50 expression vector was effectivelyhighly specific proteasome inhibitor (Fenteany et al.,
1994; Jensen et al., 1995; Craiu et al., 1997). The potent coimmunoprecipitated by the E446-1 antibody (lane 12),
suggesting that the interaction of p105 fragments withclasto-lactacystin b-lactone derivative of lactacystin
was used in these experiments because it corresponds the proteasome may occur during translation. The 497±
Cell
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Figure 6. Cotranslational Generation of p50 Is Blocked by a Specific
Inhibitor of the Proteasome
CHO-CD14 cells were transfected with a p105 expression vector Figure 7. Physical Association of p105 and Its Various Fragments
containing an N-terminal gp10 epitope tag. Cells were pretreated with the Proteasome
with 10 mM clasto-lactacystin b-lactone (lanes 1±4)or DMSO control N-terminal gp10 epitope±tagged expression vectors encoding p105
(lanes 5±8) for 1 hr before pulse radiolabeling for 20±60 min and or various C-terminal deletions were transfected into CHO-CD14
chasing for 0±60min. The resultant cell lysates were immunoprecipi- cells. After 24 hr, aliquots of cells were incubated with the MG115
tated by anti-gp10 followed by 10% SDS-PAGE. The proteasome proteasome inhibitor or DMSO. The cells were then pulse-radiola-
inhibitor was present throughout the course of the experiment. Lane beled with [35S]methionine/cysteine and chased in the presence of
9 depicts results obtained with lysates from cells transfected with cycloheximide. Lysates were immunoprecipitated with either anti-
empty vector DNA. gp10 or antibodies specific for the 20S proteasome (E446-1). Three
times the volume of the E446-1 immunoprecipitates was loaded to
visualize the radiolabeled proteasome subunits. Samples shown
in lanes 1±6 were prepared from cultures containing the MG115amino acid fragment of p105, although not generating
proteasome inhibitor, while samples shown in lanes 7±12 were pre-p50, was still coimmunoprecipitated by E446-1 (lanes 4
pared in the absence of MG115. In lane 12, the p50 fragment immu-
and 10). These interactions of the p105 fragments with noprecipitated by E446-1 migrated slightly more rapidly than the
the proteasomeappeared tobe specificbecause control sample immunoprecipitated by anti-p105 (NLS) (line 11), likely re-
Rab (HIV Rev-associated binding protein) did not coim- flecting an imperfection in the gel. The same protein exhibited nor-
mal migration in lane 6. The hemagglutinin-tagged HIV Rev-associ-munoprecipitate with the E446-1 antibody (lane 14), de-
ated binding protein (Rab, approximately 60 kD including its epitopespite being stably expressed (lane 13). Of note, the phys-
tag) was employed as a specificity control (lanes 13±14).ical association of p105 with the proteasome persists
in the presence of the MG115 inhibitor (lanes 1±6), sug-
of translation is likely the critical factor. Continuinggesting that the binding of p105 is independent of the
translation to amino acid 530, like the absence of a stopproteolytic activity of the proteasome.
codon, maintains an extended region in the nascent
polypeptide for a sufficient period of time to allow pro-Discussion
teasome processing to p50 (see model in Figure 8B).
Third, to confirm the cotranslational nature of this pro-NF-kB p50 Is Cotranslationally Generated
cess, we demonstrated in synchronized in vitro transla-by the 26S Proteasome
tion studies that p50 was produced prior to the comple-Several lines of evidence have emerged from our studies
tion of translation of the full-length protein (Figure 4).indicating that p50 is generated by a cotranslational
Finally, in sucrose gradient sedimentation studies, the
mechanism. First, ribosome halting produced by elimi-
in vitro translated nascent full-length polypeptides were
nation of the stop codon in an mRNA encoding a 497±
detected in the dense ribosome-containing fractions,
amino acid fragment of p105 results in significant pro- whereas p50 was present in the less dense top fractions,
duction of p50. In contrast, introduction of a stop codon indicating that p50 was generated while the full-length
into this same mRNA sharply inhibits p50 generation fragment was still a peptidyl-tRNA (data not shown).
(Figure 2). These findings suggest that retention of the Our studies have clearly implicated the 26S protea-
497±amino acid polypeptide on the ribosome suspends some in this cotranslational processing event. Addition
the polypeptide in an extended, relatively unfolded state of the proteasome-specific inhibitor, clasto-lactacystin
that promotes the generation of p50 (see model in Figure b-lactone, blocked the generation of p50. Prior studies
8A). In contrast, premature release of this 497-residue have demonstrated that replacement of C-terminal p105
polypeptide from the ribosome allows its complete fold- sequences located downstream of the GRR have little
ing, which effectively abrogates p50 production. effect on p50 generation (Betts and Nabel, 1996; Lin
Second, progressive repositioning of the stop codon and Ghosh, 1996). Our results now provide a potential
in the p105 mRNA revealed that translation to a point explanation for these results. Although the proteasome
between amino acids 514 and 530 permitted p50 gener- exclusively utilizes substrates that are unfolded, the par-
ation to occur in vivo (Figure 3). Relating this finding to ticular structure of the nascent p105 fragment may make
the results obtained in the ribosome-halting experiment it an acceptable substrate for the proteasome. Specifi-
cally, the loosely structured GRR may form a proximal(Figure 2), we suggest that the time, rather than distance,
Cotranslational Biogenesis of NF-kB p50
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of p105 during p50 generation could be explained in
one of two ways. First, translation of the C terminus of
p105 may be interrupted during proteasome-mediated
processing of p50, and thus the C terminus is never
made. Second, the C terminus may be translated, but
it may be continuously channeled into the barrel of the
proteasome and rapidly degraded.
NF-kB p105 and p50 Do Not Exhibit
a Precursor±Product Relationship
The pulse-chase radiolabeling studies (Figure 1) and our
other findings clearly argue against a classical precur-
sor±product relationship for p105 and p50. Functional
studies of p105 and p50 have highlighted their different
biological functions within the cell, with p50 acting as
a Rel-related transcription factor (Ghosh et al., 1990;
Kieran et al., 1990) and p105 serving as a specific cy-
toplasmic inhibitor of Rel proteins (Rice et al., 1992;
Naumann et al., 1993). In contrast to Rel complexes
sequestered by IkB-a in which this inhibitor is subject
to signal-induced complete degradation by the protea-
some (Henkel et al., 1993; Chen et al., 1995; Lin et al.,
1995; Traenckner et al., 1995), Rel complexes seques-
tered by p105 are not rapidly mobilized to the nucleus
in response to these same signals (Mercurio et al., 1993;
Sun et al., 1994; Donald et al., 1995). While the biological
Figure 8. A Model for Cotranslational Biogenesis of p50 by the Pro- function of these Rel-p105 complexes remains to be
teasome
elucidated, the candidateoncoprotein BCL-3 may mobi-
(A) Ribosome halting sustains an extended region in the nascent
lize p50 molecules bound to p105 without enhancing497-residue p105-derived fragment allowing the generation of p50.
p105 processing (Watanabe et al., 1997), suggestingIn contrast to the effects of such ribosome halting (top) that allows
that p105/p50 complexes could function as a sourceproteasome-mediated processing, premature release of the p105-
derived fragment from the ribosome by addition of a stop codon of p50 homodimers. Our studies now reveal how the
promotes rapid folding of the polypeptide and thus prevents its independent functions of p105 and p50 are preserved
processing to p50 by the proteasome (bottom). through a novel cotranslational strategy that guarantees
(B) Continuing translation is required for p50 generation. In the native
the production of both proteins. Although usually bal-situation, continuing translation serves to sustain an extended re-
anced, we have noted that the relative ratio of thesegion in nascentp105 thereby allowingprocessing by the proteasome
two products can be influenced by either changes into proceed.
(C) The nascent p105 polypeptide may enter the proteasome as a the intrinsic structure of the protein as shown in Figure
loop to allow the processing. The loosely structured GRR in the 5 or extrinsic changes in the intracellular environment;
nascent polypeptide, as well as downstream sequences displayed for example, increasing the pH of the growth medium
in an extended form due to continuing translation, may form a loop
enhances p105 production (data not shown). Overall,that is inserted through the narrow entrance of the proteasome
we suggest that these elements affect the ªstochasticallowing processing in the proteasome to proceed leading to p50
captureº of the polypeptide by the proteasome, whichgeneration. Folding of this region blocks access to the proteasome
and leads to p105 production. Similarly, cotranslational folding of is influenced by the degree of protein folding and the
the N-terminal portion of p105 may preclude its degradation by the rate of translation of p105.
proteasome. In contrast to our studies incorporating both in vitro
and in vivo approaches, the generation of p50 has pre-
viously been suggested based on in vitro analyses toportion of a peptide loop that inserts through the 13-AÊ
diameter orifice of the proteasome into its barrel, involve posttranslational processing of p105 (Palom-
bella et al., 1994). We suspect that the biological basisallowing processing to proceed (see model in Figure
8C; for structure of the proteasome, Goldberg, 1995; for p50 generation in the previous experimental setting
(Palombella et al., 1994; Orian et al., 1995) and our sys-LoÈ we et al., 1995; Weissman et al., 1995).
It remains unclear whether translation of the C termi- tem are in fact rather similar. Specifically, the in vitro
system utilized in the earlier studies may promote anus of p105 continues or is interrupted when p50 is
produced. Despiteextensive efforts, the C-terminal frag- significant degree of posttranslational unfolding that
recapitulates the conformation of the nascent poly-ment of the processed NF-kB1 gene product has never
been detected (Hatada et al., 1992; Lin and Greene, peptide, thereby allowing processing by the 26S pro-
teasome. Whereas ubiquitination is required for the ob-unpublished data). While a C-terminal fragment, termed
IkB-g, has been detected in certain mouse B cell lines, served posttranslationalprocessing of p105 (Palombella
et al., 1994; Orian et al., 1995), it is not clear whetherthis protein is apparently produced by alternate mRNA
splicing rather than p105 processing (Inoue et al., 1992; ubiquitin plays any requisite role in the cotranslational
processing that we have described.Liou et al., 1992). Lack of detection of the C terminus
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How Is the GRR Involved in Cotranslational cellsand for theselective degradation of certain proteins
under specific physiological conditions (for reviews,Generation of p50?
A 23±amino acid glycine-rich region (GRR) was pre- Rechsteiner et al., 1993; Goldberg, 1995; Jentsch and
Schlenker, 1995). These functions invariably involve theviously identified as a critical element for the generation
of p50 (Lin and Ghosh, 1996). Consistent with this obser- complete destruction of the target proteins. In contrast,
for p105, cotranslational processing by the proteasomevation, we have found that deletion of the GRR in na-
scent p105-derived fragments results in the generation yields p50. Nascent p105 fragments may be prone to
proteasome-mediated proteolysis for any of several rea-of little or no p50 (data not shown). These findings thus
demonstrate that the GRR is required for the cotransla- sons. For example, these nascent forms might be partic-
ularly susceptible to ubiquitination, thereby becomingtional generation of p50. However, our studies have fur-
ther shown that p105 proteins lacking the GRR continue preferential targets for the 26S proteasome like many
other ubiquitinated proteins. The 26S proteasomecorre-to associate with the proteasome (data not shown), indi-
cating that this element does not function as a primary sponds to a complex consisting of the 20S proteasome
and PA700 (also termed the 19S complex), which con-proteasome targeting signal. While it is clear that many
proteins are directed to the proteasome for degradation, tains ATPases, a polyubiquitin binding protein, and other
regulatory proteins (Ma et al., 1994). Alternatively, theemerging evidence suggests that some proteins may
be targeted by virtue of a chaperone-like activity of the 26S proteasome may function as a chaperone that inter-
acts directly with nonubiquitinated forms of nascentproteasome (Goldberg, 1995). As previously demon-
strated, the GRR effectively functions in the context of p105. This interaction may retain a portion of p105 in
an unfolded conformation that favors proteolysis. Rolescertain heterologous proteins (gp10-GRR-GST chimera;
Lin and Ghosh, 1996), whereas in other protein contexts for chaperone activity of the 26S proteasome have been
hypothesized previously (Goldberg, 1995) but usually in(GST-GRR-gp10), no processing occurs (Lin and Greene,
unpublished data). This latter result may reflect a dimin- the contextof ATP-dependent unfolding of the substrate
after it has been targeted to the 26S proteasome byished affinity of the N terminus of this protein for the
proteasome. ubiquitination. Recently, however, we have obtained di-
rect evidence for chaperone activity of isolated PA700
with nonubiquitinated misfolded proteins (DeMartinoNF-kB p105 as a Natural Model of Sequential
and Cotranslational Protein and Thomas, unpublished data). Such results are con-
sistent with a direct interaction of the 26S proteasomeFolding in Eukaryotes
Recently, Netzer and Hartl (1997) have proposed that with nascent forms of p105. Thus, even though our ex-
periments have utilized inhibitors and antibodies againsteukaryotic proteins undergo sequential and cotransla-
tional folding. In contrast, prokaryotic proteins seem to the 20S proteasome, it is likely that p105 processing is
catalyzed by the 26S proteasome. In fact, Sears andrely predominantly on a posttranslational mechanism
of folding for the acquisition of full biological function. Maniatis recently have identified two yeast mutants that
fail togenerate p50. These mutationsoccur inan ATPaseThese conclusions derive from the analysis of a fusion
protein containing a human H-Ras domain at the N ter- subunit and an isopeptidase subunit that are present in
the PA700 subcomplex (Sears and Maniatis, personalminus joined by a glycine-rich segment to a mouse dihy-
drofolate reductase (DHFR) domain at the C terminus. communication), thus providing additional support for
a role of the 26S form of the proteasome in generationIn these studies, the H-Ras domain was found to fold
prior to synthesis of the DHFR polypeptide. Like this of p50. Appreciable evidence now indicates a close
functional link between protease activity and chaperoneartificial fusion protein, p105 contains two functionally
independent domains linked by the GRR. Further, p50 activity in several systems, including the Escherichia
coli ClpAP and XP proteases (Gottesman et al., 1997;is generated from the N terminus prior to the completion
of C-terminal translation. We suspect that theN-terminal Suzuki et al., 1997) and the yeast PIM1 protease(Wagner
et al., 1994). Like the 26S proteasome, each of theseRel homology domain within p50 may undergo cotrans-
lational folding and thus allow this region of the protein enzymes is a large ATP-dependent protease complex
and may couple ATPase activity to a process requiredto escape proteasome-mediated degradation. Addition-
ally, such N-terminal folding may also promote rapid for proteolysis. Additional work will be required to deter-
downstream folding (as supported by stop codon scan mine whether cotranslational processing of proteins by
experiments shown in Figure 3), leading to the produc- protease-chaperones is a widespread process.
tion of p105 rather than p50. Evolutionarily, the different
Experimental Proceduresfunctions of the N- and C-terminal regions of p105 sug-
gest that this protein may have been the result of a
Antibodies, Enzymes, and Proteasome Inhibitorsgene-fusion event and that the different functions of
Antibodies specific for the nuclear localization signal of p105 and
these two domains are preserved by a novel strategy the N terminus of IkB-a (C-15) were purchased from Santa Cruz
involving cotranslational folding. The p105 protein cer- Biotechnology. Antibodies specific for the influenza hemagglutinin
tainly represents an interesting natural model to explore epitope were obtained from the Berkeley Antibody Company. Anti-
bodies reactive with the T7 gp10 epitope tag were purchased fromthe sequential and cotranslational folding of eukaryotic
Novagen. Antibodies specific for Hsc70 were a gift from Dr. Williamproteins.
Welch (University of California, San Francisco). Antibodies (E446-1)
specifically recognizing the 20S proteasome were generated by the
A Possible Novel Function of the 26S Proteasome DeMartino laboratory. The proteasome inhibitor clasto-lactacystin
The proteasome is responsible for the constitutive deg- b-lactone was purchased from CalBiochem, and the MG115 protea-
some inhibitor was obtained from Peninsular Laboratories.radation of most intracellular proteins in mammalian
Cotranslational Biogenesis of NF-kB p50
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Pulse-Chase Studies AIDS Research (P30AI27763) and by National Institutes of Health
grant RO1 DK46181 (G. N. D.).CHO-CD14 cells (Gegner et al., 1995) were seeded at 3±4 3 105
cells per 60 3 15 mm tissue culture dish 24 hr prior to transfection.
These cells were then transfected with various expression plasmids
Received December 31, 1997; revised February 9, 1998.using the LipofectAMINE reagent (GIBCO BRL). After overnight incu-
bation, the cells were washed in phosphate-buffered saline and
incubated for 1 hr at 378C in RPMI 1640 lacking methionine and References
cysteine (Mediatech). Subsequently, the cells were pulse-radiola-
beled by the addition of 200 mCi/ml of [35S]methionine/cysteine (Du- Baeuerle, P.A., and Baltimore, D. (1988). IkB: a specific inhibitor of
Pont NEN) for various periods of time and chased by removal of the NF-kB transcription factor. Science 242, 540±545.
the radiolabeled amino acids and addition of RPMI 1640 medium Baeuerle, P.A., and Baltimore, D. (1996). NF-kB: ten years after. Cell
containing cycloheximide (12.5 mg/ml, Sigma). After defined periods 87, 13±20.
of pulse or chase, the cells were lysed on ice in ELB buffer (300
Baeuerle, P.A., and Henkel, T. (1994). Function and activation of NF-mM NaCl, 0.1% Nonidet P-40, 50 mM Tris-HCl [pH 7.5], 5 mM EDTA,
kB in the immune system. Annu. Rev. Immunol. 12, 141±179.1 mM phenylmethylsulfonyl fluoride, and 1 mM dithiothreitol). The
Baldwin, A.S., Jr. (1996). The NF-kB and IkB proteins: new discover-lysates were centrifuged at 14,000 3 g for 20 min in a refrigerated
ies and insights. Annu. Rev. Immunol. 14, 649±683.microcentrifuge to remove insoluble debris. The resulting superna-
tants were precleared twice with preimmune serum and protein Beckmann, R.P., Mizzen, L.A., and Welch, W.J. (1990). Interaction
of Hsp 70 with newly synthesized proteins: implications for proteinA-Sepharose CL-4B beads (Sigma) and then immunoprecipitated
with the desired antibodies and protein A-Sepharose beads. Immu- folding and assembly. Science 248, 850±854.
noprecipitates were analyzed by 10% SDS-PAGE and fluorography. Beg, A.A., and Baltimore, D. (1996). An essential role for NF-kB in
For the in vitro pulse-chase studies, cycloheximide and RNase were preventing TNF-a-induced cell death. Science 274, 782±784.
added to terminate the translation, and lysates were removed at Beg, A.A.,Sha, W.C., Bronson, R.T., andBaltimore, D. (1995). Consti-
various time points and immunoprecipitated in ELB buffer as de- tutive NF-kappa-B activation, enhanced granulopoiesis, and neona-
scribed above. tal lethality in IkB-a-deficient mice. Genes Dev. 9, 2736±2746.
Betts, J.C., and Nabel, G.J. (1996). Differential regulation of NF-kB2
In Vitro Translation (p100) processing and control by amino-terminal sequences. Mol.
In vitro transcription and translation were performed using reagents Cell. Biol. 16, 6363±6371.
from Promega Biotech. The desired cDNA fragments were cloned
Blobel, G., and Sabatini, D.D. (1971). Dissociation of mammalianinto the pET vector (Studier et al., 1990). Plasmids were linearized
polyribosomes into subunits by puromycin. Proc. Natl. Acad. Sci.and transcribed using T7 RNA polymerase. Translation of the
USA 68, 390±394.mRNAs was performed in rabbit reticulocyte lysates in the presence
Chen, Z.J., Hagler, J., Palombella, V., Melandri, F., Scherer, D., Bal-of 0.4 mCi/ml [35S]methionine (Du Pont NEN) for varying periods of
lard, D., and Maniatis, T. (1995). Signal-induced site-specific phos-times. In experiments requiring synchronization of translation, aurin-
phorylation targets IkBa to the ubiquitin-proteasome pathway.tricarboxylic acid (Sigma) was added to a final concentration of 75
Genes Dev. 9, 1586±1597.mM 3 min after the initiation of translation (Frydman et al., 1994).
Stop buffer (20 mM Tris-HCl [pH 7.5], 5 mM MgCl2, 1 mM ATP, and Craiu, A., Gaczynska, M., Akopian, T., Gramm, C.F., Fenteany, G.,
Goldberg, A.L., and Rock, K.L. (1997). Lactacystin and clasto-lacta-2 mM puromycin) was added to the samples followed by incubation
at 258C for 5±10 min prior to immunoprecipitation. cystin b-lactone modify multiple proteasome b-subunits and inhibit
intracellular protein degradation and major histocompatibility com-
plex class I antigen presentation. J. Biol. Chem. 272, 13437±13445.Construction of p105 Deletion Mutants
Dick, L.R., Cruikshank, A.A., Grenier, L., Melandri, F.D., Nunes, S.L.,A nested series of p105 C-terminal deletion mutants were prepared
and Stein, R. (1996). Mechanistic studies on the inactivation of theby PCR using murine p105 cDNA as a template. These cDNAs were
proteasome by lactacystin. J. Biol. Chem. 271, 7273±7276.inserted into the pEVRF mammalian expression vector as described
(Lin and Ghosh, 1996). Cleavage at a unique XhoI restriction site in Dick, L.R., Cruikshank, A.A., Destree, A.T., Grenier, L., McCormack,
the p105 coding region generated a cDNA encoding an N-terminal T.A., Melandri, F.D., Nunes, S.L., Palombella, V.T., Parent, L.A., Pla-
fragment of 497 amino acids. To generate this same 497±amino acid mondon, L., and Stein, R. (1997). Mechanistic studies on the inacti-
fragment followed by an in-frame stop codon, the XhoI site was vation of the proteasome by lactacystin in cultured cells. J. Biol.
blunted using Klenow fragment and ligated to a blunted XbaI site Chem. 272, 182±188.
present in the pEVRF expression vector. The mutant p105 cDNAs Donald, R., Ballard, D.W., and Hawiger, J. (1995). Proteolytic pro-
were also subcloned into a modified pEVRF vector (pLG033a), which cessing of NF-kB/IkB in human monocytes. J. Biol. Chem. 270, 9±12.
contained an N-terminal 12-residue epitope tag from the T7 gp10.
Fan, C.-M., and Maniatis, T. (1991). Generation of p50 subunit ofAll mutations were confirmed by DNA sequencing or restriction
NF-kB by processing of p105 through an ATP-dependent pathway.mapping.
Nature 354, 395±398.
Fenteany, G., Standaert, R.F., Reichard, G.A., Corey, E.J., and
Immunoblotting Analysis Schreiber, S.L. (1994). A b-lactone related to lactacystin induces
Lysates were prepared from CHO-CD14 cells 24±48 hr after trans- neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle
fection. Aliquots of these lysates were separated on 10% SDS- progression in an osteosarcoma cell line. Proc. Natl. Acad. Sci. USA
PAGE, transferred to Immobilon-P membranes (Millipore), and 91, 3358±3362.
visualized by immunoblotting with specific primary antibodies and
Frydman, J., and Hartl, F.U. (1996). Principles of chaperone-assistedenhanced chemiluminescence (Amersham).
protein folding: differences between in vitro and in vivo mechanisms.
Science 272, 1497±1502.
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